Africa CDC’s Dr Claudia Shilumani, Rwandan Health Minister Dr Sabin Nsanzimana, Dr Githinji Gitahi, CEO of Amref Health Africa and Dr Chikwe Ihekweazu, acting WHO Regional Director for Africa

KIGALI, Rwanda – “Sad”, “Worried” and “The centre is shaking”, were some of the reactions of African health leaders to the termination of US aid at a media briefing on Sunday (2 March) ahead of the 6th Africa Health Agenda International Conference (AHAIC).

But speakers also stressed the need for resilience and swift action at the briefing ahead of the conference, which is hosted by Amref Health Africa in collaboration with Rwanda’s Ministry of Health, the World Health Organization (WHO) Africa Office for Africa, and the Africa Centres for Disease Control and Prevention (Africa CDC).

“The centre of our health system on the continent must hold,” stressed Rwandan Minister of Health Dr Sabin Nsanzimana. “Even as financing declines, we must find ways to increase it – whether through domestic sources or partnerships with those who see health as an investment in humanity.”

Nsanzimana believes Africa can find alternative funding sources to fill many of the gaps left by the massive cuts to US Agency for International Development (USAID) funding.

“There’s always money somewhere,” he explained. “When some of our medical students in surgery and midwifery were at risk of pausing their long-term training because they were supported by financing that was stopped overnight, we reassessed our priorities. we looked at cross-sector health projects and found over 5 billion Rwandan francs [over $5 million] tied up in short-term training and workshops. 

“We asked ourselves: ‘Do we keep funding weekly training that people can read online, or do we invest in long-term workforce programs?’,” he said. Rwanda has now redirected those funds to keep students enrolled, shifting the current workshops to online platforms.

Africa must “think beyond traditional funding models and use what we have to meet our most urgent needs”, he stressed.

This will be one of the pressing question considered by the over 1,800 delegates from 56 countries attending the conference.

Significant risks

“This year’s conference comes at a time of significant risks to African communities and health systems,” said Dr Githinji Gitahi, CEO of Amref Health Africa, who called for  Africa’s health systems to be redesigned to address the dual burden of infectious and non-communicable diseases (NCD).

Many African countries bear high burdens of infectious diseases while also facing a surge in non-communicable diseases

NCDs, still perceived as largely a problem of rich countries, are now a leading cause of premature deaths in Africa and Asia.

“The health system we have today is not the one we’ll need tomorrow,” said Gitahi. “[But] we have minimal fiscal space. With population growth, economic shifts, and tax inefficiencies, how do we mobilize resources to fight both infectious and non-communicable diseases with limited funds?”

“Many of us didn’t anticipate the scale of change – cuts in government assistance from not only the US government but also Germany, the UK, and others. Our current health systems have relied heavily on external support. We must rethink how to sustain them in the future,” Gitahi added.

Speakers also emphasized that ,while communities are aware of diseases like malaria and HIV, many are unaware of the risk factors driving NCDs such as cancer, cardiovascular diseases, and strokes. 

Artifical intelligence and climate change

Beyond the urgent discussions on funding, the AHAIC conference is also focusing on topics including climate-resilient health policies, the growing burden of both infectious and non-communicable diseases, artificial intelligence in healthcare, and strengthening local pharmaceutical manufacturing.

Dr Claudia Shilumani, Africa CDC director of external relations and strategic management, warned of increasing health threats linked to climate change. Africa CDC is currently monitoring 243 health threats across the continent, with 84 significant events recorded in the first few weeks of 2025.

Artificial intelligence is also a major focus, with discussions on how technology can be leveraged to improve diagnostics, treatment, and hospital management. Delegates acknowledged that while Africa needs thousands of trained professionals to meet healthcare demands, AI-driven solutions could help bridge the gap by enhancing efficiency in service delivery.

Efforts to align policies across Africa are also gaining traction. The Africa CDC is working closely with the African Medicines Agency to streamline drug approvals and distribution across the continent. There is also a push to fast-track the qualification process for local manufacturers, ensuring national health strategies align with continental frameworks like the Africa Safety Strategic Plan.

Health resilience

Dr Matshidiso Moeti, outgoing WHO Africa Regional Director, highlighted the remarkable progress Africa’s health systems have made over the years. She noted that the continent has confronted pandemics, eliminated once-deadly viruses, and turned death sentences into manageable conditions.

Despite these achievements, Moeti emphasized that significant challenges remain. She pointed to the deepening link between health, economic stability, and the environment, warning that widening economic disparities, climate change, and conflict continue to threaten healthcare systems.

“One constant has been our collective commitment to building a healthier, stronger Africa.”

Image Credits: Edith Magak, WHO/NCD Portal.

Dr Muhammad Ali Pate, Nigeria’s Coordinating Minister of Health and Social Welfare.

LAGOS, Nigeria At an HIV treatment clinic in Lagos, patients are seated in worn pews, waiting for their turn to receive their six-month supply of antiretroviral therapy (ART).

Without subsidies, the cost of these drugs could reach $4,500 a month, but with the support of foreign donors such as the US President’s Emergency Plan for AIDS Relief (PEPFAR), these patients are charged less than $2.

But the continuation of this programme is no longer assured since the Trump administration decided this week to permanently cut over 90% of US Agency for International Development (USAID) grants.

Formal notifications of contract terminations were issued from Wednesday night. HIV organisations across the continent that are funded by PEPFAR via USAID have already been informed that their grants have been terminated. 

Earlier in January, President Trump issued an Executive Order freezing USAID funding, but waivers was later granted, allowing life-saving humanitarian programmes, including HIV projects, to continue temporarily. However, in many cases this did not happen in practice as the USAID staff to ensure payment of bills had been fired.

However, some PEPFAR projects funded through the US Centers for Disease Control and Prevention (CDC) are covered by temporary waivers but they too are in jeopardy when these expire at the end of April. The reauthorisation of PEPFAR comes before the US Congress on 25 March.

“For now, we’re giving out what we have in stock. But when the drugs run out, you may have to start paying,” says the clinic’s matron, addressing the patients.

The Nigerian government is yet to comment on whether the country has been affected by the cuts. But following the Executive Orders, the country intensified focus on domestic efforts in its HIV response, which is part of a long-term strategy to reduce the impact of the USAID freeze and subsequent changes in foreign donor aid policies.

USAID support for Nigeria’s HIV response

Nigeria has the highest number of people living with HIV/AIDS in West and Central Africa, and the fourth-highest globally. 

USAID has contributed approximately $2.8 billion to the health care of Nigerians between 2022 and 2024, and this has been spent mainly on combating HIV/AIDS, malaria, tuberculosis, and polio.

In 2023, the country was on of the top 10 recipients of USAID funding, receiving over $600 million in health assistance. This aid has been directed towards efforts to prevent malaria, end HIV, deliver vaccines, and contain outbreaks.

 

PEPFAR is the country’s largest HIV donor, supporting 90% of Nigeria’s treatment burden. Its greatest contribution to Nigeria’s HIV response is in service delivery, where it has enhanced both prevention and care for those living with HIV. 

Through PEPFAR’s support, more than 1.6 million Nigerians out of an estimated two million living with HIV, now have access to antiretroviral (ARV) treatment.

Service disruption

With the pause on foreign aid, Nigeria’s HIV response, like in many other PEPFAR-supported countries, has experienced immediate service disruptions.

At the clinic, only one staff member from its PEPFAR-implementing partner showed up for work.

“There have been salary delays for health workers, and not all ad hoc staff have been called back. Covering the gaps left by these absences has been overwhelming,” says Dr Jibril Adamu, executive director of Yobe State Agency for Control of AIDS (YOSACA), one of Nigeria’s organisations coordinating HIV response at the level of the state government.

Dr Jibril Adamu, executive director of the Yobe State Agency for the Control of AIDS (YOSACA), reading a brief to the state governor.

While the limited PEPFAR waiver provided some reprieve in the fight against HIV, the inaccessibility of USAID’s payment system has caused delays in resuming distribution of foreign assistance.

As a result, many of the “life-saving humanitarian assistance programmes” cleared to resume work are unable to do so.

“PEPFAR’s continued success is hugely dependent on the survival of USAID,” says Adamu.

“The focus is now only on providing existing services, so new cases will face delays,” he explains.

This has led to reduced testing and interrupted outreach programmes, which are key to Nigeria’s progress toward HIV elimination by 2030.

The waiver also excludes high-risk groups, such as sex workers and men who have sex with men (MSM), from receiving HIV prevention medication. 

“These groups already face limited access to ART due to discrimination,” says Adamu. Nigeria’s legal system criminalises same-sex relations and considers sex work illegal.

“If no immediate action is taken, Nigeria risks a public health crisis that would have both regional and global implications,” he warns.

Increased domestic funding

“In 2024, there was significant advocacy for increased local funding and community ownership of HIV control programmes, in anticipation of when foreign partners will withdraw, as is happening now,” says Adamu. 

Within the same year, Nigeria’s national agency for HIV control held its first-ever conference on HIV prevention. Among its objectives were strategies to boost local funding efforts.

During the first meeting of the federal executive council after the USAID freeze, Nigeria’s president formed a multi-stakeholder committee to oversee its transition away from reliance on donor funding for its HIV interventions. This is coupled with a $3.2 million allocation for 150,000 treatment packs to be distributed over the next four months.

“While we greatly appreciate the US government’s contributions over the past 20 years and look forward to continued collaboration, the Nigerian government, under the president, is committed to transforming the sector by strengthening national systems, securing local financing, and exploring other funding sources to ensure that patients do not lose access to their treatment,” says Dr Muhammad Ali Pate, Nigeria’s Coordinating Minister of Health and Social Welfare, during the council meeting.

With several HIV programmes across Africa receiving letters notifying them of their contract terminations with the US government, it is only a matter of time before Nigeria knows its fate.

Meanwhile, in a recent statement issued on Thursday, Nigeria’s National Agency for the Control of AIDS (NACA) maintains that HIV treatment in government-run health facilities is still ongoing and remains free of charge

Shifting dependence

Over 81% of Nigeria’s HIV spending comes from foreign donors. “We rely heavily on them,” says Adamu. “But this is not sustainable, as it leaves the country vulnerable in the long term.”

UNAIDS: HIV funding in west and central Africa (2010-2023).

“There are viable alternatives, and it is unfortunate that we are considering them only at this stage,” says Dr Abdul Muminu Isah, principal investigator for the Person-Centred HIV Research Team (PeCHIVRet). He recommends forming partnerships with other successful countries in the Global South, incorporating HIV treatment into the national health insurance scheme, and engaging the private sector to improve service delivery.

Nigeria has announced plans to begin domestic production of HIV commodities, including test kits and antiretroviral drugs, by the end of 2025.

“Previously, we didn’t have an answer to whether Nigeria could achieve self-sufficiency, but based on recent actions, I am optimistic,” says Adamu.

Adamu adds that Nigeria has enough antiretroviral drug supplies to last until the end of the 90-day freeze, though it must find a way to prevent transmission.

He urged the international community to “balance accountability with flexibility, protecting decades of investment in HIV control and restoring the HIV response to its previous capacity, with an eye toward the 2030 target.”

Image Credits: Health Ministry of Nigeria.

Dr Ngashi Ngongo

A new and potentially more infectious variant of mpox Clade 1A has been identified in the Democratic Republic of the Congo (DRC) according to Dr Ngashi Ngongo, head of the mpox incident management team at the Africa Centre for Disease Control and Prevention (Africa CDC).

The termination of USAID funding and violence in eastern DRC are hampering mpox testing and reporting, with test results being reduced to a trickle.

Only 35% of mpox cases are currently being tested in DRC, both because of conflict and the ending of USAID funds to transport mpox tests to laboratories.

 

The DRC finally started to vaccinate people in Kinshasa this week, and uptake was swift with over 24,800 people vaccinated over four days, said Ngongo.

Mpox is continuing to spread in Uganda, which has seen case increases for three weeks in a row ​​– 278 new cases in the past week.  Mpox cases are overwhelming health facilities. For example, a treatment centre in Entebbe with 80-bed capacity currently has 102 patients.

“Because of this, the leadership in the [Ugandan] Ministry of Health has now opted also to introduce home-based care for non-severe cases,” said Ngongo.

Meanwhile, South Africa reported three mpox cases after being free of the disease for over 90 days.

The World Health Organization resolved this week to keep mpox as a public health outbreak of international concern “based on the continuing rise in numbers and geographic spread, the violence in the eastern DRC, which hampers the response, as well as a lack of funding to implement the response plan”, according to the WHO.

Febrile disease in DRC

DRC health authorities are investigating a febrile disease outbreak in five villages in the Basankusu and Bolomba health zones in Equateur province. This has tripled deaths over the past three weeks, according to WHO.

A total of 943 cases and, 52 deaths have been reported, with symptoms including fever, chills, sweating, headache and muscle pain.\, said Ngongo.

There are no haemorrhagic symptoms and Ebola and Marburg tests are negative, making malaria the most likely cause, he added.

“Children below five years make about 18% of cases with a case fatality of 5.3%. Children ages five to 15 years make up 20% of all cases, with a case fatality of 6.4%,” said Ngongo.

“The diagnostic is pointing towards malaria. Rapid tests that were conducted on over 500 samples gave a positivity rate of 55% but there are also blood smears that were also conducted, around 70 samples, that also gave a positivity rate of almost 78%,” said Ngongo.

“Further tests are to be carried out for meningitis. Food, water and environmental samples will also be analysed, to determine if there might be contamination,” according to the WHO.

“Basankusu and Bolomba are about 180 kilometres apart and more than 300 kilometres from the provincial capital, Mbandaka. The two localities are reachable by road or via the Congo River from Mbandaka. This remoteness limits access to health care, including testing and treatment. Poor road and telecommunication infrastructure are also major challenges,” saif the WHO in a statement.

Protestors gathered outside USAID headquarters in Washington D.C. after employees were informed via email to not come in to work.

The Trump administration has terminated the contracts of nearly 10,000 global health projects funded by the US Agency for International Development (USAID) or the US State Department  – including projects to provide vital diagnosis and treatment for HIV, tuberculosis, and malaria, as well as humanitarian aid projects providing nutrition and water and sanitation services.

Grants to hundreds of African HIV organisations providing life-saving services have been terminated with immediate effect via letters received on Thursday morning.  Globally, the terminated awards include 5,800 grants administered by the USAID and 4,100 grants for projects managed directly by the State Department. Some of the terminated programmes had previously been granted temporary waivers, due to their roles in providing lifesaving health or humanitarian aid.

The Trump administration also announced Thursday that it was halting US funding to the Joint UN Programme on HIV/AIDS (UNAIDS), which is headquartered in Geneva, just across from the World Health Organization.

“All malaria supplies protecting 53 million people, mostly children, including bed nets, diagnostics, preventive drugs, and treatments – terminated,” said Dr Atul Gawande, USAID’s former assistant administrator under the Biden administration.

Terminated, too, are all global tuberculosis programmes, all US-made food aid programmes, which manufacture specially enriched foods aimed at malnourished women and children, and around 1000 food kitchens serving displaced people in countries such as war-torn Sudan.

“This is one of the worst days of my professional life,” said Dr Kate Rees of Anova Health Institute in South Africa, which delivers HIV services to hard-to-reach groups. “Tomorrow, we are letting go 2,800 people who are mainly peer educators and data capturers.”

Prof Linda-Gail Bekker, CEO of the South African Desmond Tutu HIV Foundation, said that the US termination would cost 500,000 South African lives over the next 10 years and result in around half a million new HIV infections, according to recent modelling.

“As an activist, as a person living openly with HIV, I’m very hurt,” said  Sibongile Tshabalala, chairperson of the Treatment Action Campaign. “How am I going to survive? Will the public health care system be able to cater for us? Will be able to cover all the gaps that we are facing with all the challenges that the public healthcare system has?”

South Africa has the highest burden of HIV in the world with eight million people living with the virus (over 16% of the adult population).

All 44 South African HIV programmes that receive money from the US President’s Emergency Plan for AIDS Relief (PEPFAR) through USAID have seen their aid terminated. Projects affected range from mother-to-child transmission programmes and hospices to research groups. Many focus on “key populations”, groups that are the most vulnerable to HIV but often shun health centres in fear of discrimination.

“I’ve been having a sleepless night trying to think how best we can save our communities because we know that some of the government healthy facilities are very discriminatory,” said Kholi Buthelezi, national coordinator of the sex worker organisation, Sisonke.

HIV activist Sibongile Tshabalala, who lives with the virus, is fearful for her future.

HIV programmes devastated across Africa

HIV programmes across the continent have also been devastated. The Elizabeth Glaser Paediatric AIDS Foundation (EGPAF) was told to close programmes in Lesotho, Eswatini and Tanzania that cover HIV treatment for 350,000 people including almost 10,000 children.

In Uganda, for example, the Baylor College of Medicine Children’s Foundation’s HIV and TB programmes, that strengthens district health systems to better deliver HIV, TB and maternal and child services, has been terminated.

The termination letters all state that US Secretary of State Marco Rubio, in his capacity as acting administrator for USAID and Peter Marocco, USAID acting deputy administrator, “have determined your award is not aligned with agency priorities and made a determination that continuing this program is not in the national interest”.

‘Chaos and disaster’

The terminations have caused “chaos” and “disaster”, said emotional South African leaders of the HIV sector who urged their government to step in to save their programmes.

Fatima Hassan, head of the Health Justice Initiative, urged the South African government to issue compulsory licenses to reduce the price of antiretroviral medicine as the US has already “done the worst to us”.

“US Congress approved the funds, and that is what has been stopped. So we do believe that it’s an illegal grab. It’s an illegal halt of services and programs. It’s not following due process,” Hassan added.

The terminations will decimate South Africa’s HIV testing, data collection and HIV and TB literacy, said public health expert Dr Lynne Wilkinson, who added that USAID funds also assisted groups combating gender-based violence.

However, South Africa is luckier than many other African countries as it derives around 17% of its HIV budget from PEPFAR. The Democratic Republic of Congo (DRC) gets 89% of its HIV budget from PEPFAR, while Mozambique and Tanzania get 60% of their HIV budget from the US.

USAID: Countries most reliant on US aid for HIV

‘Blanket freeze is illegal’

Mitchell Warren, head of the US-based HIV programme AVAC, described the blanket termination of USAID grants as “unlawful”.

“The US government’s in a very strong position with any cooperative agreement or grant or contract. They’re allowed to cancel agreements or amend them. They’re in a very strong position generally, but the blanket freeze is illegal,” said Warren, whose organisation has resorted to the courts to prevent the cutting of lifesaving aid.

AVAC’s Mitchell Warren

“We have been now in a federal court for several weeks, and a temporary restraining order was provided two weeks ago by the Court that said that things had to go back. The tap had to be put back on until this 90 day review actually took place in a comprehensive way,” he added.

“We now have evidence entered into the public record in the courts that show the intentionality at USAID and the State Department to dismantle everything but the government has simply thrown up additional legal delays, as is their want,” said Warren.

A federal judge had set Wednesday at midnight as the deadline for USAID to release some $1,5 billion funds for the foreign aid work already completed, but the US Supreme Court granted the government a stay on the release of funds until the court could apply itself more thoroughly to the issue.

“We expect a hearing next week in Washington,” said Warren.

“This is not about PEPFAR. This is not about the HIV response. This is not about USAID. This is about the rule of law.  The United States Congress has the power of the purse. They decide what gets spent. The executive branch is there to execute, and that’s the basis of this legal argument.

“But as of [Wednesday] night, they began to basically massacre every possible implementing agency to deliver on this work. This court case, as important as it is, is not going to change that overnight. That’s why working in partnership with each other and with national governments is essential because the United States is not a partner that is trustworthy  right now,” Warren concluded.

Image Credits: Reuters Youtube, Gandhi A, et al, Annals of Internal Medicine, 11 Feb. 2025, UNAIDS.

Marie Grace Pendo needed a mechanical valve for her heart when she was nine years old.

KIGALI, Rwanda – When Marie Grace Pendo was nine years old, she flew from Rwanda to India with a group of other patients and her doctor to have a mechanical valve implanted in her heart.

Pendo had rheumatic heart disease, usually caused by an untreated bacterial infection. She had little energy and her life was in danger. With only one cardiologist in Rwanda at the time – 2016 – she had little chance of receiving the life-saving operation. The Rwandan government paid for her travel and operation in India.

Pendo, now aged 20, tells Health Policy Watch that she is on blood thinners for life but other than that, lives a normal life under the care of health workers at Masaka District Hospital.

If she needed the operation now, she could stay in the country as Rwanda is slowly producing more cardiologists. There are currently six, with four more due to graduate within months.

Dr Everiste Ntaganda, director of cardiovascular disease at the Masaka Hospital, says Pendo’s medication and monthly consultations are covered by the country’s compulsory Community-Based Health Insurance (CBHI), introduced in Rwanda in 2004 as part of the country’s rollout of universal access to healthcare (UHC).

In 2003, only 7% of people had health insurance but currently, over 80% of the country’s 14 million citizens are part of the  CBHI, the highest universal health coverage rate of any low-income country (LIC).

The CBHI is funded by members’ premiums, taxes, and donor funding. Premiums are based on people’s income with people divided into six categories, paying zero (Category 1) to around $6 a year. Most people pay around $2 annually in Rwanda, which derives its main income from agriculture. 

Not all treatments are covered by the CBHI but the country is adding to what is available each year and treatment for breast cancer has been included for the first time this year. Rwandans are expected to pay 10% of the cost for treatments and medicines that are not covered – but that lies way beyond the reach of most people. In the poorest cases, the government endeavours to shoulder the entire cost.

Reorganisation of health services

When Paul Kagame came to power in 1994 after the genocide in which approximately one million people were killed, he made health a key pillar of rebuilding the country.

Rwanda- decentralisation of NCD care

From a highly centralised system, the country has decentralised its health services, including the management of non-communicable diseases (NCDs), to reach more people closer to their homes to minimise transport costs.

Masaka is in the midst of a huge Chinese-enabled revamp that will almost triple its beds and, once completed it will become a teaching hospital.

The hospital caters for half a million people and its focus is on NCDs, said Dr Jean Damascene Hanyurwimfura, the hospital’s Director-General, pointing to the 2023 statistics which show 46% of deaths in facilities and 61% in communities are NCD-related.

“We decentralised because we can’t keep treating everyone at the hospital,” explains Dr Francois Uwinkindi, manager of NCDs at the Rwanda Biomedical Centre, which is the implementation arm of the health ministry.

Dr Francois Uwinkindi, head of NCDs at the Rwanda Biomedical Centre

“Before this, people could also spend $20 on transport which was higher than the cost of their healthcare.”

Rwanda has focused on NCD prevention and succeeded in reducing tobacco consumption, almost halving its use from 13% of the population in 2012 to 7%, said Uwinkindi.

But it hasn’t been able to reduce alcohol consumption, which has increased from 41% in 2012 to 48%. Hypertension and obesity are also up, although these are still a modest 17% and 4% respectively as the vast majority of the agrarian population gets enough exercise through their work. 

Rwanda’s capital city, Kigali, holds monthly car-free Sundays that not only prohibit vehicles in certain areas but are designed to encourage physical activity. Screenings for NCDs include diabetes and hypertension are also offered at some of the car-free days.

Community health workers in every village

The base of the country’s decentralised health services rests squarely on the shoulders of over 58,000 community health workers (CHW). These CHW are elected by village and town meetings, positions that mostly appeal to older residents. 

Each village elects four CHW who are allocated around 60 households to interact with.

Like in most African countries, the CHW are volunteers – but when budget allows, they get a little performance-related stipend, says Emery Hezazira, who heads the country’s CHW programme.

They need to be over the age of 21 and have completed primary school with good literacy and numeracy skills, as well as holding the trust of their communities, according to a health ministry document.

The document lists the CHW’s 15 tasks including diagnosing and managing malaria and tuberculosis cases, providing basic maternal and child care, managing childhood illnesses and conducting awareness campaigns about mental health and behavioural disorders.

They encourage behaviour to prevent NCDs, promote nutrition and promote HIV awareness.

“There is no fixed remuneration, CHWs receive their community performance-based financing (CPBF) on quarterly basis. The CPBF depends on the performed priority indicator, available funds, weight and unit cost of each indicator,” according to the document.

The CHWs are supervised and managed by the health centres, essentially primary healthcare clinics. The health centres are managed by district hospitals.

About 1000 CHW are active around Masaka, and they help to drive prevention messages, according to Uwinkindi.

During the recent Marburg outbreak, they went door-to-door in affected communities encouraging anyone with a fever and symptoms to go to their closest health facility.

In future, the health authorities want ongoing community awareness and education about NCDs and CHW to do more NCD screening. But as demands on CHW grow, so too may pressure to pay them –  challenge faced by all African countries that have introduced CHW.

Elderly women with alzheimer's sit together
A group of older women socialise at Ukingu village in Geita region, with Hadija Kisanji on the far right.

GEITA, Tanzania —The first time 78-year-old Hadija Kisanji got lost on her way home, neighbors found her sitting under a baobab tree, staring blankly at the dusty road. When they asked where she was going, she whispered, “I think I live nearby.” That was three years ago. Today, Kisanji barely remembers her own name.

She’s amongst the many elderly Tanzanians silently battling dementia—a condition often mistaken for witchcraft. In a country where mental illness is stigmatized, dementia is not just an illness—it is a slow erasure of identity, leaving families struggling in isolation.

A life fading away

Alzheimer's dementia tanzania
Hadija Kisanji, 78, who suffers from dementia sits with her daughter Mariam and grandchildren.

Kisanji’s daughter, Mariam, has watched helplessly as her mother plunges further into confusion. “She calls me ‘mother’ sometimes,” Mariam told Health Policy Watch. “She doesn’t remember I am her child. She asks if her parents are coming back, but they’ve been dead for 50 years.”

In rural Tanzania, where medical facilities are scarce, dementia and Alzheimer’s remain largely undiagnosed. Families struggle to manage symptoms – wandering, memory loss, aggression – without professional guidance. “Some believe that when old people start acting strangely, they are bewitched,” said Mfaume Kibwana, Chief Medical Officer at  Geita Regional Referral Hospital. “It’s heartbreaking because dementia is a disease, not a curse to dispel. Yet many remain blinded by mistaken beliefs in witchcraft, and changing their minds isn’t easy.”

For Kisanji, the disease has turned her life into a puzzle of lost time. Once a respected midwife, she now spends her days clutching a stuffed teddy bear, convinced it is her real baby. “Shhh, don’t wake him,” she whispered to this reporter, holding the doll firmly in her frail arms.

A town struggling to understand

Geita, a region in northwestern Tanzania, near the southern shores of Lake Victoria and the Rwandan border.

Geita, a gold-mining region in north-western in Tanzania, near the Rwandan border and the shores of Lake Victoria, lacks specialized dementia care. The few health centres available are overstretched. Many families never seek medical attention, assuming dementia is a natural part of aging or fearing social stigma.

Even when families try to access care, the costs are prohibitive. “The doctor said my father needs special medicine,” says Juma Magesa, whose 82-year-old father, Mzee Rashid, was diagnosed with Alzheimer’s. “But where do I get 200,000 shillings ($80) every month when I can hardly feed my children?”

Magesa has resorted to tying a small bell to his father’s wrist. “At night, he tries to leave the house. If I hear the bell, I wake up and stop him.”

Social isolation worsens the situation. “People stopped visiting us,” says Rehema Komba, who takes care of her 89-year-old mother Joseline Kombe. “They say she is bewitched. Even my own relatives tell me to take her to a witch doctor instead of a hospital.”

A glimpse across Africa

Alzheimer's in Africa
Joseline Kombe, 89, (on right) sits with relatives who are weaving baskets.

The struggle of dementia patients in Tanzania reflects a broader crisis across Africa, where ageing populations are rising but geriatric healthcare remains underdeveloped. The World Health Organization estimates that by 2050, nearly 10% of Africa’s population will be over 60.

Dementia is already on the rise in Sub-Saharan Africa, with 2.13 million people affected in 2015—a figure projected to soar to 7.62 million by 2050.

A daring thief of memory and autonomy, dementia now affects over 55 million individuals globally, with nearly 10 million new cases emerging each year. Alarmingly, more than 60% of those living with dementia reside in low- and middle-income countries, where resources for care and support are often scarce. 

The economic toll of dementia is staggering. In 2019, the global cost was estimated at US$1.3 trillion, a figure projected to rise to US$1.7 trillion by 2030, and potentially US$2.8 trillion when accounting for increases in care costs. Informal caregivers, often family members, shoulder approximately half of these expenses, dedicating an average of five hours daily to care and supervision. 

People living with dementia could triple by 2050

Beyond the financial strain, dementia casts a profound shadow on human lives. It is currently the seventh leading cause of death worldwide and a major contributor to disability and dependency amongst older adults. Women are disproportionately affected, both as patients and caregivers; they account for 70% of care hours provided to those living with dementia. 

As the global population ages, projections indicate that the number of people living with dementia could triple by 2050, reaching 152 million. This looming crisis underscores the urgent need for comprehensive public health strategies, increased awareness, and robust support systems to address the multifaceted challenges posed by dementia. 

The World Health Organization’s member states recognized dementia as a public health priority in 2017, endorsing a Global Action Plan (2017-2025), due to come up for review at this year’s May World Health Assembly. This plan provides a comprehensive blueprint for action across seven strategic areas, including increasing awareness, reducing risk, and providing support for caregivers. 

But the growing burden of dementia also highlights potential opportunities for the African continent to innovate and develop interventions. Experts convening in Nairobi at last year’s inaugural Nature conference on brain health and dementia noted that researchers could gain valuable insights into risk factors through the study of Africa’s very diverse populations, leading to the development of more effective as well as affordable interventions for dementia worldwide. 

“With 80% of the people with dementia likely to be in the Global South by 2050, it’s imperative that we bring the high-resource communities and the Global South together to solve the problem,” said George Vradenburg, founder of the Davos Alzheimer’s Collaborative, which co-sponsored the event.

The burden of care

In many or most African households, caregiving typically falls on the shoulders of women—daughters, granddaughters, or wives. 

Mariam, for instance, quit her job as a teacher to care for her mother full-time. “It is like watching a candle burn out,” she says. “One day, she knows who I am. The next, she doesn’t even recognize her own face in the mirror.”

With no nursing homes or hospice care, families rely on each other. “I can’t leave her alone,” Mariam says. “She might wander into the street. She might fall into the fire while cooking.”

Dr Kibwana warned that caregivers, too, suffer silently. “They develop anxiety, depression, even physical health problems from stress. But they don’t talk about it because, in our culture, taking care of your parents is a duty, not a choice.”

A mother forgotten

Alzheimer's elderly Tanzania dementia
Rehema Magesa, 81, walks outside her house in Geita. She doesn’t remember her name.

 An old woman sat on a wooden stool outside a crumbling mud-brick house, her faded khanga wrapped tightly around her frail shoulders. Her eyes, clouded with confusion, darted back and forth, as if searching for something just beyond reach. The late afternoon sun bathed her wrinkled face in gold, but there was no warmth in her expression – just an emptiness that had swallowed the person she used to be.

Her name is Rehema Magesa, or at least that’s what her family tells her. She does not remember. At 81, Alzheimer’s and dementia have stolen the sharp-witted woman who once ran a thriving fish stall at the Mwanza market, and raised six children with the strength of a lioness. Now, she barely recognizes them. She calls her eldest son “Baba” and mistakes her teenage granddaughter for the neighbor’s child. Some days, she accuses her own family of stealing her money – money she hasn’t earned in years.

Inside the house, her daughter Halima stirs a pot of thin maize porridge, her face drawn with exhaustion. “She wakes up at night and wanders,” Halima said, glancing toward the door, as if fearing her mother might slip out again. “Last week, we found her on the road to the lake, barefoot, shivering. A stranger had to bring her home.” There’s no money for a caretaker, no proper medication, no respite. The family struggles to make ends meet, and Magesa – once the pillar of the household – has become its heaviest burden.

At dusk, she sits quietly, tracing invisible patterns in the dust with her fingers. Her son, Rashid, watches from a distance. “She carried me on her back when I was a baby,” he said. “Now, she doesn’t even know who I am.”

Fighting a ‘big war with small weapons’ 

Healthcare in Tanzania
Caption Dr. Wilfred Chuwa of Bugando Regional Referral Hospital, attending to a patient in Mwanza.

Tanzania’s healthcare system has made progress, but dementia care remains overlooked in national policy. There are no awareness campaigns, no government-funded housing for older people, and no formal support networks for caregivers, leaving families to navigate the challenges alone.

Experts warn that dementia cases will rise sharply as the country’s ageing population grows. “We are sitting on a time bomb,” said Dr Kibwana. “If we do nothing, thousands of elderly people will suffer in silence, and families will continue to bear a heavy burden.”

Some grass roots organizations are trying to fill the gap. A local NGO in the port-city of Dar es Salaam , The Good Samaritan Social Service Tanzania, has started training community health workers to identify and recognize dementia symptoms. “We go door to door, talking to families,” said volunteer Neema Kijazi. “We tell them, ‘Your mother is not possessed. She is sick.’”

But resources are limited. “We need more training, more medicine, more doctors,” Kijazi said. “Right now, we are fighting a big war with small weapons.”

Ageing in poverty

Dementia care is just one part of a larger crisis facing Tanzania’s elderly. In a country where more than half the population is under 18, older people are often overlooked. Life expectancy remains low—68.4 years for women and 65.2 for men—but those who surpass this threshold face a brutal reality, where survival is a daily battle.

“Our bodies are fragile. As  we grow old, our strength and vitality diminish while ill health set in with a devastating impact,”said Zena Mabeyo professor of social welfare at the Institute of Social Work in Dar Es Salaam.

But for most people she knows, retirement is a foreign concept. Nearly 96% of older Tanzanians keep working out of necessity, tending small farms, selling vegetables, or weaving mats. The fortunate ones own a few goats or chickens—their version of a “bank account.”

“Diminishing strength and stamina obviously affects the kind of work that elderly people can do and how long they can do it,” Mabeyo told Health Policy Watch.

Those too frail to work rely entirely on their families’ support. Tanzania has no universal pension system, and only former government employees receive stipends – although too small to sustain them.

The gradual breakdown of both traditional and modern support systems has left many elderly Tanzanians struggling to survive.

Although the country has recognized ageing in its national policy, this is a largely rhetorical gesture, critics say. Policies fail to effectively address the needs of older people, and particularly those suffering from dementia and Alzheimer’s.

“We haven’t seen meaningful interventions for older people with dementia and Alzheimer’s in Tanzania,” Mabeyo said. “Without a clear strategy for diagnosis, care, and support, many elderly people continue to suffer in silence.”

Prioritizing dementia in Africa

Alzheimer's aging elderly Tanzania
Maria Maserere, another local resident with dementia, sits outside her home in Gaita’s rural environs.

Public health experts like Dr Kibwana urge Tanzania and other African nations to prioritize dementia as a public health issue. They stress the need for awareness campaigns, caregiver support programs, and affordable medication. Without these measures, they warn, thousands of families will continue to struggle alone, and the silent suffering of the elderly will only worsen.

For now, Mariam and many others remain trapped in a cycle of care and grief, hoping for a future where their loved ones can live with dignity, not in the shadows.

Each day is a battle against the unknown. “I don’t know how long I can do this,” she admits. “I pray that one day, someone will help us.”

Juma echoes her fears. “We are drowning,” he says. “Nobody sees us, nobody hears us.”

As the darkness sets in Geita, Kisanji sits on the squeaking wooden bench, humming an old Sukuma(tribe) lullaby. For a brief moment, she looks at Mariam and smiles. “Mama,” she says softly.

Mariam squeezes her mother’s hand, holding onto that fleeting moment of clarity. Because tomorrow, Kisanji may forget again. And all Mariam can do is wait – and remember for both of them.

Image Credits: Kizito Makoye Shigela/HPW, Google Maps , Kizito Makoye Shigela/HPW, Muhidin Michuzi.

Dr Adriana Blanco Marquizo, Head of the Secretariat of the WHO FCTC (center) at a 20th anniversary press briefing of the Convention’s entry into force.

Global tobacco use prevalence has dropped by one-third, and there are now an estimated 118 million fewer tobacco users in the world today, as compared with 2005, said Dr Adriana Blanco Marquizo, Head of the Secretariat, on Tuesday. 

She was speaking at a WHO press conference marking the 20th anniversary of the WHO Framework Convention on Tobacco Control (WHO FCTC), which entered into force on 27 February, 2005. 

In other successes, : She added that, “138 countries require pictorial health warnings on tobacco products, and dozens of countries require plain packaging measures, which require a standard shape and appearance without branding design or a logo on cigarette packages. 

Countries with best practices on restrictding tobacco advertising, 2020.

“Both measures reduce tobacco consumption and warn users about the dangers of tobacco. Up to 66 countries have implemented bans on tobacco advertising, promotion and sponsorship in response to a tobacco industry that spent tens of billions of dollars on promoting their products and hooking new generations.”

All in all, some 5.6 billion people are covered by at least one tobacco control measure – although a full suite of measures is critical to reduce tobacco use prevalence, she stressed. 

“But while there have been great gains in tobacco control over the last two decades, there is a long way to go. 1.3 billion people are estimated to still use tobacco products globally, and tobacco use is one of the leading factors for non communicable diseases, including heart disease, stroke, chronic respiratory diseases, diabetes and cancer,” she noted. 

Affecting climate, environment and sustainable development 

Preparing to plant tobacco in Malawi. Workers are exposed to toxins both from the fertiliser used and nicotine in seeds.

In addition, tobacco use affects climate, environment and sustainable development, she pointed out. 

“The economic cost of smoking, from health expenditure to productivity losses, is estimated at 1.8% of annual GDP, and most of this burden is felt in developing countries,” Marquiso said.

“The environmental burden of tobacco use must also be acknowledged. 

“Billions of cigarette butts are discarded every year into our environment, one of the largest  forms of plastic pollution in the world, and valuable resources such as agricultural land and water are wasted on growing tobacco instead of food. Production and consumption of tobacco also contributes to climate change, releasing 80 million tons of carbon dioxide in the air every year.”

Meeting new challenges in products, social media and illicit trade 

Ms Kate Lannan, Senior Legal Affairs Officer, WHO FCTC Secretariat.

In terms of implementing the FCTC, a range of new challenges have emerged from an industry that has creatively developed new ways to sidestep Convention measures, and get smokers hooked. 

Heated tobacco products and nicotine vaping have become widely popular – and while the smoking prevalence rates contain some data on heated tobacco products, “it’s not a complete picture” said Kate Lannan, Senior Legal Affairs Officer in the FCTC Secretariat.  That’s because countries are only just now updating national surveys to include these new modes of tobacco and nicotine delivery. “So it depends on what their latest survey includes.”

At the same time, while vaping nicotine in some kind of chemical formulation remains a grey area, heated tobacco products are fully covered by the Convention, Lannan said. 

“”They are tobacco products. The implementation of the Convention should also cover heated tobacco products to the same extent as all other tobacco products, which means surveillance, monitoring, etc.”

Another challenge is new media.  While facing strict curbs on traditional advertising modes, like TV, billboards, and packaging, it has developed a strong presence in social media forms – which has proven much harder to regulate. 

New guidelines on social media 

Heated tobacco products, social media and illicit trade pose new challenges for tobacco use control.

Just last year, the FCTC Conference of Parties (COP 10) adopted new “guidelines” on Article 13 of the Convention, which addressed tobacco advertising, to address social media, entertainment platforms, cross border streaming services, and media influencers “who are able to reach our young people in a way that simply wasn’t envisioned at the time of the entry into force of the Framework Convention,” Lannan said, adding, “These specific guidelines are sort of activating the convention in a new way to specifically address those issues.” 

Marquiso called on more FCTC member states to follow the guidelines for developing more comprehensive bans on tobacco advertising, including “social media advertising and sponsorship deals.”

Finally, while many countries have raised taxes on tobacco products sharply, cross-border trade in cheaper illicit products has flourished in many regions and countries of the world.  

In 2012 the Protocol to eliminate illicit trade in tobacco products, was adopted by member states, although work to advance enforcement is still ongoing today, Marquiso noted.  

“This work addresses the threat posed by the illicit trade of tobacco, which undermines control measures, diminishes tax revenues and fuels criminal activities.” 

Finishing outstanding business 

School-based arts and craft project In Krygyzstan promotes anti-tobacco education.

Marquiso also called upon WHO member states, who have not done so yet, to implement bans on smoking in indoor places. 

“Smoke-free laws have been enacted covering more than a quarter of the world population, protecting people from the dangers. “This has proven itself to be one of the most cost effective tools at reducing consumption, and we call on more countries to implement these measures,” she said. 

She described political will and interference from the tobacco industry as the biggest single barrier to better implementation and enforcement of the FCTC.

“We have a lot of requests from countries to help them technically in implementing measures. 

“But I think the most important thing that countries will need to do in order to be able to implement the treaty is to be aware of the interference of the tobacco industry. 

“We need more political will. And it’s not an easy moment, given the geopolitical situation in this moment in the world.  And we need more awareness of the interference of the industry and how to stop that interference.” 

Image Credits: WHO, WHO Report on the Global Tobacco Epidemic, bacco Report, 2021 , Josephine Chinele, pixabay.

Health workers at the National Health Command Center in Saudi Arabia’s Ministry of Health.

Make “Health in All Policies” a global and national priority to improve health and reduce healthcare spending long-term, says a senior Saudi health official, Dr Nouf Al Numair.

The health of a nation’s population is a critical determinant of its economic productivity, educational outcomes, and the sustainability of its healthcare systems. Yet health considerations are often overlooked in policymaking as many view them solely as the duty of the healthcare system, not recognizing that health is a shared responsibility shaped largely by policies beyond the healthcare sector.

 As a result, healthcare costs continue to rise, outpacing economic growth. A report from the World Health Organization (WHO) shows that global spending on health increased to $9.8 trillion (10.3% of global GDP) in 2021. Similarly, PwC’s Health Research Institute (HRI) projects an 8% year-on-year global increase in medical costs by 2025. This immense increase in expenditure is a result of global and national inaction.

Evidence suggests that integrating health considerations across all policy areas – commonly referred to as the Health in All Policies (HiAP) approach – yields significant benefits for population health, health equity and socioeconomic resilience. 

By addressing the root causes of poor population health and well-being, commonly known as risk factors and the underlying drivers behind the burden of disease, HiAP can reduce healthcare spending in the long run. Therefore, HiAP must become a global priority to reduce spending on treatment and shift the focus from treatment to prevention.

 HiAP is a framework that acknowledges the multidimensional influences on health, extending beyond the healthcare sector to areas such as education, employment, urban planning, and environmental policy. Health is a shared responsibility that requires collaboration across all sectors to address its social, economic, and environmental determinants.

Proactive primary prevention

Ensuring access to healthy, fresh foods is but one example of an HiAP approach that can generate a cascade of health and economic benefits.

Research shows that socioeconomic factors such as income, housing, and access to education play a substantial role in shaping health outcomes. For example, a 2021 study published in The Lancet demonstrates a clear correlation between cross-sector policy integration and improvements in population health indicators, particularly in non-communicable diseases and health equity.

Demographic projections and trends further emphasize the urgency of adopting the HiAP framework that promotes proactive primary prevention over reactive treatment. By 2030, an estimated 1.4 billion people–approximately one in six globally–will be aged 60 or older, with this figure expected to reach 2.1 billion by 2050.

As longevity increases, policymakers are shifting their focus from extending lifespan to enhancing health span– the number of years lived in good health while remaining economically and socially productive. 

Initiatives such as the UK’s National Health Service program, Adding Years to Life and Life to Years, and Finland’s National Health Promotion Policy underscore this transition, prioritizing primary prevention and quality-of-life improvements.

Finland’s North Karelia Project, launched in the 1970s, is a leading example of a prevention-first approach, helping reduce cardiovascular disease mortality by over 80% in four decades through dietary improvements, tobacco control, and physical activity promotion.

Multi-sectoral approach

Sprinkling salt on tomatoes
Saudi Arabia has launched an initiative to reduce salt consumption, a key risk factor for hypertension and cardiovascular disease.  

Saudi Arabia, through Vision 2030, has made significant progress in population health over recent decades. Life expectancy has increased from 46 years in the 1960s to 76 years in 2020

The Saudi Ministerial Committee for HiAP, established in 2018 under a Royal Decree and chaired by the Minister of Health, institutionalizes this approach. It brings together over 10 ministries, spanning Education, Labor, Environment, Economy, Sport, Housing, and Urban Development, to align policies that promote health and to ensure they do not harm population health and health equity across sectors.

This multi-sectoral approach has made progress across the Kingdom, delivering concrete results. One example is Saudi Arabia’s initiative to reduce salt consumption, a key risk factor for hypertension and cardiovascular disease. Recognized by the World Health Organization, this initiative–led by the Saudi Food and Drug Authority in collaboration with the Ministry of Health, manufacturers, and importers–demonstrates how policy interventions targeting both supply and dietary habits can contribute to improved cardiovascular health outcomes.

These measures align with WHO recommendations for reducing premature mortality from NCDs by one-third by 2030, a key Sustainable Development Goal (SDG 3.4) as well as Saudi Vision 2030’s goal of fostering a thriving society.

The economic benefits of health-conscious policymaking are well-documented. A healthier population contributes to increased labour productivity and reduced healthcare expenditures. A 2020 analysis by the Organization for Economic Cooperation and Development (OECD) found that investments in preventive health measures generate an average return of 4:1 in economic benefits by reducing healthcare costs and improving workforce efficiency.

Sustainable health improvements

Despite these advantages, challenges remain in fully integrating health into all sectors of policymaking. Effective implementation requires a whole-of-government approach, sustained inter-ministerial coordination, governance, robust data collection and analysis, capacity building, and long-term financial commitments, strong legislative and regulatory frameworks, and continuous advocacy efforts.

However, evidence from countries with established HiAP frameworks, such as Finland and South Australia, suggests that the systematic integration of health into public policy decisions can reduce health disparities and improve national resilience. Saudi Arabia’s HiAP model provides a valuable case study for other nations seeking to implement similar frameworks.

 As healthcare systems worldwide contend with rising demands, adopting a multi-sectoral, primary preventive approach is increasingly recognized as a viable strategy for sustainable health improvements.

 Ongoing monitoring and data-driven analysis will be essential for refining and scaling such frameworks to ensure that healthy public policymaking remains a central component of national development strategies at both regional and global levels.

Governments worldwide must prioritize HiAP to enhance population health, curb rising healthcare costs and build resilient societies. Policymakers must collaborate across sectors to create long-term policies that protect and promote health. HiAP practitioners should engage in global discourse, share best practices, and invest in evidence-based strategies that advance health equity and well-being.

The time to act is now – to secure a healthier, more prosperous future for generations to come.

Dr Nouf Al Numair is the Secretary General of Saudi Arabia’s Ministerial Committee for Health in All Policies

Image Credits: Department of Labor, Saudi Arabia, World Bank Tanzania/Twitter , WHO/S. Volkiv.

Encephalitis, the inflammation of the brain, can cause long-term damage. Its current global burden is unknown.

Encephalitis “remains under-recognized, under-diagnosed, and underfunded”,  according to a new policy report from the World Health Organization (WHO).

Climate change, vaccine hesitancy, and the rising burden of vector-borne diseases are also fuelling an increased number of encephalitis cases, a rare but serious inflammation of the brain. 

The technical document urges coordinated global action to “confront and tackle the growing public health threat from encephalitis,” and points to prevention strategies, as well as gaps in diagnosis, research, treatment, and care. 

“Unless prompt action is taken, encephalitis will continue to drive avoidable deaths and disability,” notes Encephalitis International, a global advocacy non-profit.

“Regrettably, the withdrawal of support for the WHO and potential dissolution of USAID by President Donald J Trump’s Administration, among other recent executive actions, threaten to worsen an already challenging situation,” said the non-profit in a statement.

The report comes as measles, which in some cases can cause encephalitis ,continues to plague higher-income countries, including a recent outbreak in West Texas, where a “close-knit, undervaccinated” Mennonite community is at the epicentre of a 58-person outbreak.

Vaccine skeptics received a strong boost in the confirmation of Robert F Kennedy Jr as Secretary of the Department of Health and Human Services. The Secretary spent more than 30 years sowing doubt as to the safety of vaccines. Measles, mumps, and rubella–diseases prevented by routine childhood vaccines–can also in some cases cause encephalitis. 

‘Life-threatening’ brain inflammation

Encephalitis, the swelling of the brain, affects people across all age groups, and has high mortality rates. 

“Unlike other organs or organ systems, the brain is very sensitive to swelling and inflammation…when the brain is injured, it can have permanent effects on the brain’s function – like walking, talking, even causing seizures,” said Dr Youssef Kousa, a neurologist and founder of the Zika Genetics Consortium at Children’s National Hospital, in an interview with Health Policy Watch.

“For a lot of encephalitdes, there are no treatments.”

The condition often leads to significant long-term complications including hearing loss, seizures, limb weakness, and difficulties with vision, speech, language, memory and communication, according to the WHO.

Globally in 2021, encephalitis was the fourth leading cause of neurological health loss in children under five years and the 13th across all age groups. The report notes that in the same year, over 80,000 people died from encephalitis and up to 50% of people with encephalitis suffered long-term after-effects of the condition, losing “independence, income and quality of life.”

Underdiagnosed and lacking political commitment

Encephalitis mortality map
Mortality from encephalitis is the highest in South and South-East Asia, where Japanese Encephalitis Virus is likely to continue spreading.

“Encephalitis is a growing public health challenge, and by prioritizing it within global and national health agendas and strengthening collaboration, we can reduce its impact and save lives,” said Dr Tarun Dua, head of the Brain Health Unit at the WHO, in a press release. 

“These efforts will not only improve health outcomes and quality of life for those affected and their families but also result in stronger, more resilient health systems.” The Brain Health Unit at WHO was only formed in 2020, as a growing number of brain-related conditions affect both lower and higher income countries, notably Alzheimer’s, Parkinson’s, epilepsy, and encephalitis. 

“I sit here just as Oropouche virus is increasing in cases in South America, right now and as yet, barely studied. Without surveillance, this virus will continue to spread almost unnoticed,” said Dr Aline MB Matos, a neurologist from São Paulo, Brazil, at the report’s launch on Wednesday.

“Encephalitis today is not a funding priority in many low and middle income countries, not because it is not important, but because these countries face multiple crises. Lack of clean water, limited access to education, an overburdened healthcare system, armed conflicts. And as a reality, it is difficult to choose what to prioritize.

“But encephalitis must be a priority.”

Diagnosis in lower-and-middle income countries is especially difficult, because the condition requires a confirmatory lumbar puncture, and sometimes highly specialized tests such as brain imaging and electroencephalography (EEG). However, as the report notes, and as Matos highlighted in her remarks, most of the world’s population lives in areas with no immediate access to comprehensive or rapid encephalitis diagnostics. 

“In many countries, lumbar punctures are performed on only some of the people with suspected brain infections. This may be due to a lack of trained workforce or procedural kits, and misconceptions about lumbar puncture indications and safety,” noted the report. 

But even in higher-income countries, there are only so many treatments for the viruses that cause encephalitis, said Kousa. Even if Zika or West Nile Virus can be diagnosed more readily in the US, providers have nearly the same limited treatment options as those in lower-income countries. 

Vector-borne diseases pose new threat 

Although JEV is rare, the mosquito-borne disease can have a case-fatality rate as high as 30%.

Several pathogens can cause encephalitis, with the herpes simplex virus being the most common cause of the condition, according to the WHO. But other viruses, notably vector-borne diseases, are a rising threat for encephalitis. 

Dengue, Zika virus, and oropouche virus are all increasing in incidence and prevalence in South America, the Caribbean, and South and South-East Asia, as warming climates, deforestation, and urbanization spur mosquitoes into closer proximity to humans. Almost half of the global population is now at risk for these diseases.

Recent dengue outbreaks have plagued the Indian subcontinent, and oropouche virus, a relatively rare vector-borne disease, is likely to see case levels similar to last year’s record-breaking season.

Also of concern is Japanese Encephalitis virus (JEV), which has now spread to 24 South-East Asia and Western Pacific countries, including Australia, and a novel tick-borne encephalitis. 

“We do not know the full number of encephalitis cases worldwide, but we do know that infectious causes play a major role, and in low and middle income countries, many of these pathogens are either emerging or being neglected,” said Matos. The problem is only exacerbated by climate change, as previously uninhabitable regions become mosquito breeding grounds. 

“This renders large populations at increasing risk of vector-borne diseases such as arboviruses,” noted the report.

While these diseases have few – or even no – vaccines, some more established, and vaccine-preventable diseases, are seeing a resurgence.

Encephalitis-inducing viruses can be prevented by vaccines, such as influenza, varicella-zoster virus (VZV), rabies, poliomyelitis, and measles, mumps and rubella (MMR). The COVID-19 pandemic-related disruptions in routine immunizations and vaccine hesitancy have left experts worried about encephalitis cases due to MMR. 

“Vaccine hesitancy is an issue for us, and it’s part of this bigger picture science skepticism and false information. So it’s up to us as a community to push out the right messages,” said Dr Tom Solomon CBE, a neurologist at Liverpool University Brain Infections Group, at the report launch. Solomon is also President of Encephalitis International and an advisor to the WHO

Hopes that WHO support will lend greater awareness

encephalitis international 2025 event
Experts convened in London to discuss the impact of the WHO’s new brief. From left: Dr Tom Solomon, Dr Benedict Michael, Dr Aline MB Matos, and Dr Nicoline Schiess.

For Professor Benedict Michael, a neurologist at the University of Liverpool, the new report “puts encephalitis on the map,” building on the advocacy successes in the past decade. While epilepsy and Parkinson’s have garnered more attention on the brain health front, the experts gathered at the Encephalitis International-WHO launch hope that the report will improve public health policies, including vaccine programs and vector control. 

“Encephalitis is just one example of why working together matters. From COVID-19 we learnt diseases do not respect borders, politics or ideologies. They affect us all,” said Dr Aline MB Matos.

Understanding the disease burden through improved surveillance, and improving patient care in rehabilitation and access to healthcare were also high on the priority list.

“Our recent research has shown that many of the interventions needed to improve diagnosis and treatment of encephalitis are not particularly expensive. A lot of it is about increasing surveillance and recognition of the condition, providing simple equipment for early diagnosis, and making sure the right treatments, many of which are very affordable, are available,” said Solomon.

The report points to several key factors that would reduce the burden of encephalitis, stating countries should prioritize relevant medicines for inclusion into national essential medications lists and standardized treatment protocols, include both autoimmune and infectious encephalitis and their treatments in publicly funded UHC packages, use and expand existing surveillance systems for forecasting demand and supply chains, and pair better availability and affordability of medicines with appropriate training and education of the health workforce to recognize and treat encephalitis in a timely manner. 

“There’s huge potential for this technical brief to have genuine global impact that’s transformative in the brain health agenda,” concluded Benedict.

Image Credits: Flickr: Florey Institute of Neuroscience & Mental Health, WHO, WHO, Encephalitis International.

Dr Tedros addresses the closing session.

Negotiators working to nail down the pandemic agreement have offered assurances that they can meet the May deadline – for the sake of global security and to restore faith in multilateralism.

Despite only five formal days of talks remaining in April, Pakistan’s Umair Khalid said his country believes there is enough time to clinch the agreement. 

“I don’t think any treaty is negotiated and agreed within a 9am-to-6pm, Monday to Friday setting. So you always have to put in some extra hours, and we have been doing that, and  we’ll continue to do that,” Khalid told a gathering of civil society groups meeting in Geneva during lunchtime on Friday.

“We will use March, we will use April, and we will use all the time that we have.”

India’s Dr Pradeep Khasnobis said that talks “are moving forward” and that “some of those very tough articles, at least have some kind of a landing zone”. 

Eswatini, speaking for the African region, Egypt and Sudan in the closing session, described the week’s talks as “constructive”.

“While we acknowledge concerns about the moderate pace, we are optimistic that the remaining issues, though critical, are manageable,” said Eswatini. 

“We must prepare to conclude our discussions in the five days allocated for the month of April, and we thank the Bureau for proposing additional discussions to address these gaps. We are ready to burn the midnight oils.”

The Philippines, speaking for a 11 diverse countries including Brazil, Canada and the UK, stressed the importance of reaching agreement to restore faith in multilateralism.

“Given the increased challenges facing this organisation, and multilateralism itself, there is a need to demonstrate that countries can indeed come together to solve common problems. We did this in May when we amended the International Health Regulations. This year, we need to adopt the WHO Pandemic Agreement,” said the Philippines, adding that member states managed to make “incremental improvements” to the text “by really listening to one another”.

“We have sat together in this room too many times over the last three years to not have a decent understanding of each other’s positions. We all have some sense of what the consensus text should look like,” id added.

“Let us finish what we have started. Adopting a meaningful Pandemic Agreement will be a win for all of us. The conclusion of the pandemic agereement in May will be a testimony to the world of our commitment to global health and of the continuing relevance of WHO in a time of major political challenges.”

Colombia’s Maria Tenorio Quintero told the civil society gathering that meeting the May deadline would take “extra effort”, and appealed to civil society to help raise public awareness about the positive impact that the agreement could have.

Norway’s Eirik Bakka stressed that the draft agreement “is not an empty shell, and there are important elements that are already agreed to bring it to the finishing line”.

‘Use every opportunity to find common ground’

Joining the closing session, Dr Tedros Adhanom Ghebreyessus, World Health Organization (WHO) Director-General, said that the 13th meeting of the Intergovernmental Negotiating Body (INB) had made progress – but “maybe not as much as you would have hoped”.

“As you move to finalize the pandemic agreement in time for the World Health Assembly, you have one week of formal negotiations left. 

“But you’re so close, closer than you think. You’re on the cusp of making history. This agreement should not fail on a word; it should not fail on a comma and it should not fail on a percentage.

 “History will not forgive us if we fail to deliver on the mandate the world needs, and a sign that multilateralism still works. Reaching a WHO pandemic agreement in the current geopolitical environment is a sign of hope.”

Tedros concluded with two messages: “We believe you can do it” and “Use every opportunity during the intercessional period to come closer together towards finding common ground.”

Civil society anxiety

Nina Jamal of Four Paws and KEI’s Jamie Love.

Civil society organisations following the pandemic agreement negotiations over the past three years are anxious that it won’t be completed by May – and that impetus for the initiative will fizzle and further undermine multilateralism.

A sombre group of over 75 people met in person and online in Geneva over lunch on Friday to express frustration at the slow pace of talks over the past five days. 

With only five official negotiating days remaining – 7-11 April – many complex parts of the agreement are not agreed. The group also raised concerns about provisions being watered down of provisions, particularly on technology transfer and intellectual property, and the absence of clauses on prevention.

Knowledge Ecology International’s Jamie Love expressed disappointment over “the lowering of the ambitions on the initial versions of the text and watering down of provisions”.

He also raised that it may suit some parties, particularly the European Union, not to have an  agreement in May given the “rise of the anti vaxxers and right-wing populism”.

Ellen ‘t Hoen of Medicines Law and Policy described reaching agreement as “crucial now in the current political context and the huge global health crisis caused by the United States withdrawal of aid and European countries slashing their aid budgets”.

“This makes the need for having a signal that multilateralism still works even more important than in the earlier days of the pandemic. This total lack of international solidarity is of huge concern.”

Meanwhile, Four Paws’ Nina Jamal said member states seemed to accept the importance of the agreement for multilateralism

However, Jamal added that pandemic prevention offers the best chance to protect people in countries with weak health systems.

“This is the deepest level of equity that we can achieve. And we are disappointed because a lot of countries who  support prevention and are taking action nationally on prevention with a One Health approach are not being vocal in the negotiations because they think if they talk about prevention, they’re disadvantaging their negotiating position for medical countermeasures, preparedness and response.”